Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma

This publication has 48 references indexed in Scilit:

• Integrating Constitutive Gene Expression and Chemoactivity: Mining the NCI60 Anticancer Screen
  PLOS ONE, 2012
• The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations
  Genes & Cancer, 2012
• Selective and Cell-Active Inhibitors of the USP1/ UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
  Chemistry & Biology, 2011
• The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
  Blood, 2011
• Glioblastoma chemotherapy adjunct via potent serotonin receptor‐7 inhibition using currently marketed high‐affinity antipsychotic medicines
  British Journal of Pharmacology, 2010
• Small molecule regulators of autophagy identified by an image-based high-throughput screen
  Proceedings of the National Academy of Sciences, 2007
• Delusional parasitosis: A dermatologic, psychiatric, and pharmacologic approach
  Journal of the American Academy of Dermatology, 1993
• Changes in Food Intake and Stomach Contents of Tumor‐Bearing Rats After Treatment With Dopamine Antagonists
  Nutrition and Cancer, 1989
• Inhibition of growth of C6 astrocytoma cells by inhibitors of calmodulin
  Life Sciences, 1985
• Alterations of Phospholipid Metabolism in Rat Cerebral Cortex Mince Induced by Cationic Amphiphilic Drugs
  Journal of Neurochemistry, 1981